期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝门部胆管癌的外科治疗

下载PDF
导出
摘要 肝门部胆管癌是指肝总管、左右肝管及其汇合部发生的恶性肿瘤，也称为近端胆管癌或高位胆管癌。1957年Altemeier首先报告，但直到1965年有学者报道13例肝门部胆管癌患者诊治资料后才广泛引起重视^[1]。有文献报道美国肝外胆管癌每年发病人数约为3000例^[2]，但国内迄今尚无肝门部胆管癌发病率报告。
作者 朱化刚
机构地区 安徽医科大学第一附属医院普外科
出处 《临床外科杂志》 2010年第2期79-81,共3页 Journal of Clinical Surgery
关键词 肝门部胆管癌 术前评估 手术 争议
分类号 R735.8 [医药卫生—肿瘤]
  • 相关文献

参考文献14

  • 1耿小平,朱化刚.肝门部胆管癌诊治进展[J].临床外科杂志,2006,14(2):72-74. 被引量：7
  • 2Ito F,Cho CS,Rikkers LF,et al.Hilar cholangiocarcinoma:current management[J].Ann Surg,2009,250(2):210-218.
  • 3D'Angelica MI,Jarnagin WR,Blumgart LH.Resectable hilar cholangiocarcinoma:surgical treatment and long-term outcome[J].Surg Today,2004,34(11):885-890.
  • 4Jarnagin WR,Fong Y,DeMatteo RP,et al.Staging,respectability,and outcome in 225 patients with hilar cholangiocarcinoma[J].Ann Surg,2001,234(4):507-519.
  • 5黄志强.肝门部胆管癌外科治疗的现状与我见[J].中国实用外科杂志,2007,27(5):341-346. 被引量：78
  • 6周宁新,黄志强,冯玉泉,顾万清,张文智,黄晓强.肝门部胆管癌根治性切除手术方式的改进[J].中华普通外科杂志,2001,16(2):82-84. 被引量：72
  • 7Neuhaus P,Jonas S,Bechstein WO,et al.Extended resections for hilar cholangiocarcinoma[J].Ann Surg,1999,230(6):808-818.
  • 8Mu(n)oz L,Roayaie S,Maman D,et al.Hilar cholangiocarcinoma involving the portal vein bifurcation:long-term results after resection[J].J Hepatobiliary Pancreat Surg,2002,9(2):237-241.
  • 9Ikeyama T,Nagino M,Oda K,et al.Surgical approach to Bismuth type I and II hilar cholangiocarcinomas:audit of 54 consecutive cases[J].Ann Surg,2007,246(6):1052-1057.
  • 10Nagino M,Kamiya J,Nishio H,et al.Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer:surgical outcome and long-term follow-up[J].Ann Surg,2006,243(3):364-372.

二级参考文献20

  • 1黄志强.肝门部胆管癌外科治疗面临的问题与出路[J].中华实验外科杂志,2004,21(7):773-775. 被引量：78
  • 2Lillemoe KD, Cameron JL. Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach [ J ]. J Hepatobiliary Pancreat Surg, 2000, 7(2):115-121.
  • 3Otto G, Romaneehsen B, Lotichius MH, et al. Hilar cholangiocarcinoma: respectability and radieality after routine diagnostic image[J].J Hepatobiliary Pancreat Surg, 2004, 11(5):310-318.
  • 4Chamberlain RS, Blumgart LH, Hilar cholangiocarcinoma:a review and commentary[J ]. Ann Surg Oncol, 2000, 7( 1 ) ; 55-66.
  • 5D' Angelica MI, Jarnagin WR, Blurngart LH. Resectable hilar cholangiocarciaoma: surgical treatment and long - term outcome [ J ]. Surg Today, 2004, 34( 11 ) : 885-890.
  • 6Singhal D, van Gulik TM, Gouma DJ. Palliative management of hilar cholangiocarcinoma[ J ]. Surgical Oncology, 2005,14 (2):59-74.
  • 7Patel AH, Harnois DM, Klee GG, et al. The utility of CA 19 - 9 in the diagnoses of cholangiocarcinoma in patients without primary schrosing cholangitis[ J ]. Am J Gastroenteml, 2000, 95( 1 ) :204-207.
  • 8Levy C, Lymp J, Angulo P, et al. The value of serum CA19 - 9 in predicting cholangiocarcinoma in patients with primary selerosing cholangitis [ J ]. Digestive Diseases and Sciences, 2005, 50 (9) : 1734-1740.
  • 9Zervos EE, Osborne D, Goldin SB, et al. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach[J]. Am J Surg, 2005, 190(5):810-815.
  • 10BurKe EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinincal staging system [ J ]. Ann Surg, 1998, 228(3) :385-394.

共引文献154

临床外科杂志
2010年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部